6849.T Stock - Nihon Kohden Corporation
Unlock GoAI Insights for 6849.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $225.42B | $221.99B | $206.60B | $205.13B | $199.73B |
| Gross Profit | $114.30B | $111.35B | $105.93B | $109.09B | $102.23B |
| Gross Margin | 50.7% | 50.2% | 51.3% | 53.2% | 51.2% |
| Operating Income | $20.71B | $19.59B | $21.12B | $30.99B | $27.09B |
| Net Income | $14.10B | $17.03B | $17.11B | $23.43B | $18.24B |
| Net Margin | 6.3% | 7.7% | 8.3% | 11.4% | 9.1% |
| EPS | $84.87 | $101.22 | $101.64 | $138.26 | $107.11 |
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
6849.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | $23.30 | $26.90 | +15.5% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $2.45 | $0.84 | -65.7% | ✗ MISS |
Q2 2025 | May 12, 2025 | $44.08 | $36.38 | -17.5% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $21.77 | $46.36 | +113.0% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $26.50 | $-1.81 | -106.8% | ✗ MISS |
Q3 2024 | Aug 2, 2024 | $4.01 | $4.57 | +14.0% | ✓ BEAT |
Q2 2024 | May 13, 2024 | $87.32 | $108.34 | +24.1% | ✓ BEAT |
Q1 2024 | Feb 2, 2024 | $35.89 | $-0.85 | -102.4% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $42.20 | $50.03 | +18.6% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $28.53 | $45.02 | +57.8% | ✓ BEAT |
Q2 2023 | May 15, 2023 | $33.29 | $98.06 | +194.6% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $18.65 | $3.79 | -79.7% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $22.36 | $57.78 | +158.4% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $8.99 | $43.65 | +385.5% | ✓ BEAT |
Q2 2022 | May 13, 2022 | $53.16 | $77.17 | +45.2% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $48.14 | $54.49 | +13.2% | ✓ BEAT |
Q4 2021 | Nov 8, 2021 | $94.85 | $91.47 | -3.6% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $12.74 | $53.38 | +319.0% | ✓ BEAT |
Latest News
Frequently Asked Questions about 6849.T
What is 6849.T's current stock price?
What is the analyst price target for 6849.T?
What sector is Nihon Kohden Corporation in?
What is 6849.T's market cap?
Does 6849.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 6849.T for comparison